Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole injection vs lansoprazole injection for peptic ulcer bleeding
CTR20180638Phase 3Completed
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexlansoprazole in upper gastrointestinal bleeding (UGIB), Peptic ulcer disease (PUD), sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started May 2018; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on CTR20180638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180638.